Notably, a recent cross-sectional, explorative study investigating possible associations of vitamin D in CSF with biomarkers for AD, including tau protein and phosphorylated tau protein, revealed that higher levels of 25(OH) vitamin D were significantly associated with lower levels of tau protein as well as phosphorylated tau protein [191]. The gene discussed is MAPT; the disease is Alzheimer disease.